Atalar et al. (2019) found elevated galectin-3 levels in prediabetic and DM patients, suggesting that galectin-3 might be associated with inflammation, metabolic syndrome, and conditions such as insulin resistance and beta-cell dysfunction. Here, LGALS3 is linked to metabolic syndrome.